Job title: CEO
Dr. Hsiao is the Chief Executive Officer, President and Co-Founder at Acepodia, Inc. He was awarded Dr. Y-T Lee Prize, which named after Nobel Laureate Dr. Lee, for his research achievement in Chemistry. Dr. Hsiao has extensive research experiences in immune cell therapies, which lead to the discovery of ACC™ (Antibody-Cell Conjugation) technology, and to the invention of the novel cellular immunotherapy, ACE™ (Antibody-Cell Conjugation Effectors). Dr. Hsiao is an inventor of several patents and patent applications covering ACC and Natural Killer & T cell therapies. Dr. Hsiao earned his BS in Chemistry from National Taiwan University, and his PhD in Chemistry and Molecular Cell Biology from the University of California, Berkeley.